FG
MRK icon

Fairman Group’s Merck MRK Stock Holding History

Fairman Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.6K Sell
669
-121
-15% -$14.2K 0.07% 81
2026
Q1 		$95.7K Hold
790
– – 0.08% 74
2025
Q4 		$83.8K Hold
790
– – 0.07% 79
2025
Q3 		$66.9K Hold
790
– – 0.05% 91
2025
Q2 		$63.2K Sell
790
-123
-13% -$9.78K 0.05% 93
2025
Q1 		$93.3K Sell
913
-518
-36% -$48.4K 0.09% 78
2024
Q4 		$143K Sell
1,431
-18
-1% -$1.86K 0.12% 68
2024
Q3 		$166K Hold
1,449
– – 0.15% 64
2024
Q2 		$180K Hold
1,449
– – 0.18% 59
2024
Q1 		$192K Sell
1,449
-640
-31% -$78.9K 0.18% 52
2023
Q4 		$229K Buy
+2,089
New +$217K 0.22% 44

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fairman Group's MRK Position: Q2 2026 in Review

Fairman Group reduced its Merck (MRK) stake by 15% in Q2 2026, selling an estimated $14.2K and leaving 669 shares worth $86.6K. The position accounts for 0.07% of the portfolio, ranked #81.

Fairman Group first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $229K in Q4 2023. 3,844 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fairman Group held 669 shares of Merck worth $86.6K as of Q2 2026.
  • Fairman Group sold 121 Merck shares in Q2 2026, an estimated $14.2K.
  • Merck made up 0.07% of Fairman Group's portfolio in Q2 2026, its #81 holding.
  • Fairman Group first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's Merck position peaked at $229K in Q4 2023.
  • 3,844 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.